FDA approves gene therapy to treat adults with Metastatic Synovial Sarcoma EP News Bureau Aug 5, 2024 Among the 44 patients in the trial who received Tecelra, the overall response rate was 43.2 per cent and the median duration of…
Gilead gets US FDA Accelerated Approval for Trodelvy to treat metastatic urothelial cancer EP News Bureau Apr 14, 2021 New indication marks secondFDAapproval for Trodelvy in 2021
